PATHEON N.V. Financial Statements (2026 and earlier)

Company Profile

Business Address EVERT VAN DE BEEKSTRAAT 104
AMSTERDAM SCHIPHOL, 1118 CN
State of Incorp.
Fiscal Year End October 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

4/30/2017
Q2
1/31/2017
Q1
10/31/2016
Q4
7/31/2016
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments90,400166,400740,400
Cash and cash equivalent89,000165,000738,800
Short-term investments1,4001,4001,600
Receivables422,600409,700414,100
Inventory, net of allowances, customer advances and progress billings407,200395,200391,700
Inventory407,200395,200391,700
Other undisclosed current assets28,80020,10020,900
Total current assets:949,000991,4001,567,100
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization1,004,200983,600960,500
Long-term investments and receivables11,30011,50012,200
Long-term investments11,30011,50012,200
Intangible asset, including goodwill, after accumulated amortization522,700529,200535,900
Goodwill281,500281,600281,800
Intangible asset, excluding goodwill, after accumulated amortization241,200247,600254,100
Deferred costs   63,700
Other noncurrent assets44,40044,10045,700
Deferred tax assets, net59,400 14,500
Other undisclosed noncurrent assets 47,50080,100 
Total noncurrent assets:1,689,5001,648,5001,632,500
TOTAL ASSETS:2,638,5002,639,9003,199,600
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:354,500393,600378,300
Interest and dividends payable20,90014,00034,800
Taxes payable 9,1006,6001,900
Employee-related liabilities71,00081,80081,800
Accounts payable248,200279,300244,000
Accrued liabilities4,9008,8007,800
Other undisclosed accounts payable and accrued liabilities4003,1008,000
Debt19,60019,500620,400
Deferred revenue and credits158,800154,200150,000
Other undisclosed current liabilities9,1006,6001,900
Total current liabilities:542,000573,9001,150,600
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,086,6002,099,5002,092,400
Long-term debt, excluding current maturities2,086,600 2,092,400
Other undisclosed long-term debt and lease obligation  2,099,500 
Liabilities, other than long-term debt315,700247,800319,300
Deferred revenue and credits98,900102,300101,600
Deferred tax liabilities, net69,800 90,800
Other liabilities147,000145,500126,900
Other undisclosed noncurrent liabilities  67,100 
Total noncurrent liabilities:2,402,3002,414,4002,411,700
Total liabilities:2,944,3002,988,3003,562,300
Equity
Equity, attributable to parent(305,700)(348,400)(362,700)
Common stock1,6001,6001,600
Additional paid in capital595,400591,400586,000
Accumulated other comprehensive loss(88,900)(99,300)(64,100)
Accumulated deficit(813,800)(842,100)(886,200)
Other undisclosed equity(100)  
Total equity:(305,800)(348,400)(362,700)
TOTAL LIABILITIES AND EQUITY:2,638,5002,639,9003,199,600

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

4/30/2017
Q2
1/31/2017
Q1
10/31/2016
Q4
7/31/2016
Q3
Revenues457,400510,200482,000
Cost of revenue
(Cost of Product and Service Sold)		(327,700)(351,000)(332,800)
Gross profit:129,700159,200149,200
Operating expenses(82,400)(88,400)(91,300)
Other operating income (expense), net(3,600)3,500(6,500)
Other undisclosed operating loss(3,500)(4,000)(2,400)
Operating income:40,20070,30049,000
Nonoperating income (expense)(5,000)2,0003,200
Investment income, nonoperating   
Gain (loss), foreign currency transaction, before tax(4,800)2,5003,200
Other undisclosed income before gain (loss) on sale of properties  3,100 
Other nonoperating expense(200)(500) 
Interest and debt expense(3,300)(10,100) 
Income from continuing operations before equity method investments, income taxes:31,90062,20052,200
Other undisclosed loss from continuing operations before income taxes(24,900)(42,400)(43,100)
Income from continuing operations before income taxes:7,00019,8009,100
Income tax expense (benefit)21,30024,300(300)
Income from continuing operations:28,30044,1008,800
Income before gain (loss) on sale of properties:28,30047,2008,800
Net income:28,30047,2008,800
Other undisclosed net loss attributable to parent  (3,100) 
Net income available to common stockholders, diluted:28,30044,1008,800

Comprehensive Income ($ in thousands)
Annual | Quarterly

4/30/2017
Q2
1/31/2017
Q1
10/31/2016
Q4
7/31/2016
Q3
Net income:28,30047,2008,800
Other undisclosed comprehensive loss  (76,000) 
Comprehensive income (loss):28,300(28,800)8,800
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10,40037,70012,600
Comprehensive income, net of tax, attributable to parent:38,7008,90021,400

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: